Acute lung injury market seen reaching $3.19 billion by 2030

The acute lung injury market is projected to grow from $2.59 billion in 2025 to $3.19 billion by 2030, according to The Business Research Company. Growth is tied to rising respiratory disease cases, new treatment approaches, and broader critical care capacity across major regions.

Why it matters: - Acute lung injury is a life-threatening condition that can require urgent intensive care and advanced respiratory support. - The market outlook points to continued demand for treatments, monitoring tools, and hospital-based critical care infrastructure. - Rising respiratory disease burden, including pneumonia, continues to feed clinical need for acute lung injury care.

What happened: - The Business Research Company released The Acute Lung Injury Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on October 29, 2026. - The report estimates the acute lung injury market will rise from $2.59 billion in 2025 to $2.71 billion in 2026. - The report projects the market will reach $3.19 billion by 2030. - The report puts the market on a 4.4% CAGR from 2025 to 2026 and a 4.2% CAGR through 2030. - North America held the largest regional share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - Acute lung injury is marked by widespread inflammation and lung damage that disrupts oxygen exchange. - The condition can stem from direct causes such as pneumonia and physical trauma to the lungs. - The condition can also arise from indirect causes including sepsis and pancreatitis. - Symptoms commonly include difficulty breathing, low oxygen saturation, and respiratory distress. - Historical market growth has been supported by high pneumonia incidence, trauma-related lung injuries, limited advanced ventilation options, stronger critical care awareness, standardized fluid management protocols, and hospital-centered treatment patterns. - Future growth drivers include pharmacological treatments targeted at acute lung injury, wider use of artificial intelligence in patient monitoring, more intensive care units globally, personalized therapy approaches, and minimally invasive ventilation methods. - Reported market trends include more ALI cases worldwide, greater use of mechanical ventilation, broader use of pharmacotherapy and fluid management, earlier diagnosis and monitoring, and continued expansion of hospital critical care infrastructure. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, and key technology and future trend analysis. - The Business Research Company offers a free sample report and the full market report.

Between the lines: - The forecast suggests the market is expanding, but not at a breakout pace. - The strongest near-term gains appear tied to incremental improvements in diagnosis, monitoring, and ventilation rather than a single disruptive therapy. - Regional growth in Asia-Pacific may reflect expanding critical care capacity and broader access to treatment in emerging markets. - The report's emphasis on AI and personalized care signals a shift toward more data-driven and tailored ICU management.

What's next: - The market will likely track broader respiratory disease trends, especially pneumonia and other conditions that increase acute lung injury risk. - Adoption of newer pharmacological and minimally invasive approaches could shape treatment patterns through 2030. - Hospitals and care systems in fast-growing regions may drive the next phase of demand for critical care technologies and services. - The report's outlook suggests steady expansion rather than volatility, with annual gains building over time.